Search results for "slas europe 2018"
Selected Filters:
New UHPLC system at the ACS Fall Exposition 2008
Magic™ Anti-troponin I monoclonal antibody, clone 20D8
- Manufacturer
 - Creative Diagnostics
 - Catalog Number
 - DMAB-L21004
 - Host
 - Mouse
 - Reactivity
 - Human
 - Applications
 - Flow Cytometry
 
Mouse Anti SARS-CoV-2 Spike (S2) Antibody (0018)
The Native Antigen CompanyMouse anti SARS-CoV-2 Spike (S2) antibody (0018) is a monoclonal antibody that recognizes the SARS-CoV-2 Spike S2 glycoprotein. This antibody has been manufactured for use in Western blot and ELISA immunoassay development. Antibody does not recognize SARS-CoV-2 Spike S1 glycoprotein.
2019-nCoV Nucleocapsid Recombinant Antigen, full length (Ag-6)
Merck2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)
2019-nCoV Assays for Detection of SARS-CoV-2
MerckPrimer and probe pools for the U.S. CDC and and Charité tests.
Vote for Best New Drug Discovery & Development Product of 2018 in the Scientists’ Choice Awards
To help shape future technologies — and be in with a chance of winning a $500/£400/450 € Amazon Gift Card — cast your vote for the product which made the most difference to the lab in 2018
AACC 2018: Handheld POC Analyzers, Innovative Sepsis Solutions and Liquid Biopsy Platforms Steal the Show
Find out what caused a real buzz at the 70th Annual Scientific Meeting and Clinical Lab Expo
First In Vivo Proof-of-Concept Data With CD8+ CAR-Treg Presented at FOCIS 2018
Significant impact on mice survival and skin graft rejection vs. control in relevant GvHD and skin transplant models
Waters Unveils New Technologies for Food Safety, Food Authenticity and Biomedical Research at ASMS 2018
Waters demonstrates the power and potential of mass spectrometry by showcasing new technologies
Rigaku Technologies Introduces Rigaku NEX LS Scanning Multi-element Process Coatings Analyzer at Pittcon 2018
Rigaku NEX LS scanner performs multi-element composition, coat weight and coating thickness analyses for web and coil applications
Qureight’s 3D AI imaging platform to support Calluna Pharma’s Phase 2 IPF Trial of CAL101 in idiopathic pulmonary fibrosis
CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF



















